ArticleFrontiers in pharmacology2022

A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma.

Xiaoxia Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.